Registration Now Open for BOS Events 2024!

Bio2Business Ltd is delighted to open registration for BOS Events 2024 which includes: BOS Basel 2024, which will take place on the 19th and 20th of June at Congress Centre Basel; and BOS Manchester 2024, which will take place on the 26th and 27th of November at Manchester Central.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for virtual events during 2024. We look forward to welcoming you and your colleagues to BOS Events 2024! Please contact the Bio2Business team for further details.

Featured Company (BOS Basel 2023)

ICROM SRL
ICROM srl is an Italian CDMO dedicated to the development and the GMP manufacture of Active Ingredients and Intermediates for pharmaceutical use on a small, medium and large scale.
ICROM holds segregated GMP units for the development and manufacture of high-potent APIs mainly for oncological application,...
View profile

Featured Speaker (BOS Manchester 2023)

Development of Phase Appropriate Drug Products and Management of the CMC Minefield in an Outsourced Environment

Dr Kreshnik Hoxha, Director of CMC and Clinical Supply Chain, Grey Wolf Therapeutics

ABSTRACT: The interface between a biotech sponsor and the CDMO is a focal point where the CMC success or challenge takes place. In his talk, Kreshnik will be elaborating on the fine balancing act between developing phase appropriate formulations that ensure speed to clinic versus excessive development endeavours that lose sight of the overall objective.
He will be speaking in a dual capacity: as someone who has worked within a CDMO with biotech clients, but also as a biotech Head of CMC, who drives drug development in an outsourced environment.
Case studies highlighting technical challenges... Click here to Read More